
During the Abu Dhabi Future Health Summit, M42 and Lunit signed a strategic partnership agreement to explore the application of population-scale AI for earlier cancer risk identification and screening. The partnership brings together Lunit’s cutting-edge AI research and development capabilities from South Korea with M42 and Abu Dhabi’s clinical, technology and data assets, creating new opportunities to advance more proactive and data-driven approaches to cancer care. The agreement was signed by Kareem Shahin, Chief Executive Officer, Digital Health Solutions Platform, and Group Chief Digital Officer, M42, and Brandon Suh, CEO of Lunit, with Antoine Khoury also joining the signing ceremony. By combining advanced AI with trusted health data and clinical expertise, the collaboration reflects a shared ambition to identify risk earlier, strengthen screening and support the shift towards more predictive and preventive models of care at scale. #M42 #FutureHealthSummit2026

































